Physician profile
Dennis Prok
NPI 1255846382
$3,606.40
in general payments reported to CMS, 2019-2025
15 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.16 · 2022: $593 · 2023: $1,527 · 2024: $932 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.62 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,131.54 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $686.77 | 2021-2025 | |
| Axsome Therapeutics, INC. | $678.45 | 2023-2025 | Sunosi |
| Inspire Medical Systems, INC. | $458.49 | 2022-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $159.84 | 2023-2025 | Lumryz |
| Merck Sharp & Dohme LLC | $141.63 | 2022-2023 | Belsomra |
| Fisher & Paykel Healthcare INC | $105.75 | 2024-2025 | Fisher & Paykel Healthcare |
| Idorsia Pharmaceuticals US INC | $66.99 | 2022-2023 | Quviviq |
| 3b Medical, INC. | $44.10 | 2024 | Luna |
| Eisai INC. | $37.09 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.75 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.75 | 2024 | Horizant |
| Zoll Respicardia, INC. | $18.96 | 2024 | Remede System |
| Insmed, INC. | $17.39 | 2025 | Brinsupri |
| Philips North America LLC | $15.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Prok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.